RI 36 (Oxymorphone hydrochloride extended-release 7.5 mg)
This pill with imprint "RI 36" is Gray, Round and has been identified as Oxymorphone hydrochloride extended-release 7.5 mg. It is supplied by Ranbaxy Pharmaceuticals Inc..
Oxymorphone is used in the treatment of pain; labor pain and belongs to the drug class narcotic analgesics. Risk cannot be ruled out during pregnancy. Oxymorphone 7.5 mg is classified as a Schedule 2 controlled substance under the Controlled Substance Act (CSA).
Oxymorphone hydrochloride extended-release
- Imprint:
- RI 36
- Strength:
- 7.5 mg
- Color:
- Gray
- Shape:
- Round
- Availability:
- Prescription only
- Drug Class:
- Narcotic analgesics
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- 2 - High potential for abuse
- Labeler / Supplier:
- Ranbaxy Pharmaceuticals Inc.
- National Drug Code (NDC):
- 63304-0219
More about oxymorphone
- Side Effects
- During Pregnancy
- Dosage Information
- Drug Images
- Drug Interactions
- Support Group
- Pricing & Coupons
- En Español
- 200 Reviews – Add your own review/rating
- Drug class: narcotic analgesics
Consumer resources
- Oxymorphone
- Oxymorphone extended-release tablets
- Oxymorphone suppositories
- Oxymorphone tablets
- Oxymorphone (Advanced Reading)
- Oxymorphone Injection (Advanced Reading)
Other brands: Opana, Opana ER, Numorphan
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
